跳至主要内容
临床试验/EUCTR2016-002680-34-ES
EUCTR2016-002680-34-ES进行中(未招募)1 期

Effects of different concentrations of dexmedetomidine on basal ganglia neuronal activity (local field potentials) in Parkinson's disease.

Clínica Universidad de Navarra/Universidad de Navarra0 个研究点目标入组 12 人开始时间: 2016年8月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients undergoing placement of DBS for PD in two phases.
  • 2. The patient must be of legal age (> 17 years old).
  • 3. The patient or his representative has consented to participate in the study.
  • 4. The patient should, in the investigator's opinion be able to cooperate during the procedure.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 4
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • 1. Known liver disease.
  • 2. Pregnant or nursing women.
  • 3. History of hypersensitivity to dexmedetomidine.
  • 4. Heart block (2nd or 3rd degree), without pacemaker.
  • 5. Symptomatic hypotension.
  • 6. Severe stroke or other neurological deficits that may impair adequate cooperation or observation of the study endpoints

研究者

相似试验